Home/Filings/4/0001493152-23-003227
4//SEC Filing

Ohri Manu 4

Accession 0001493152-23-003227

CIK 0000109657other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 6:02 AM ET

Size

5.6 KB

Accession

0001493152-23-003227

Insider Transaction Report

Form 4
Period: 2023-01-27
Ohri Manu
Chief Financial Officer
Transactions
  • Award

    Option to purchase Common Stock

    2023-01-27+500,000500,000 total
    Exercise: $0.84Exp: 2033-01-26Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.

Documents

1 file

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1
  • filerCIK 0001424683

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:02 AM ET
Size
5.6 KB